NCT07776353 Understanding New Cachexia Subtypes Through Observational Epidemiological Research Status RECRUITING Phase N/A
NCT07751133 Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07721740 Using Patient Navigation to Promote Bowel Screening in AAA Attendees. Status NOT_YET_RECRUITING Phase NA
NCT07649525 Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level Status RECRUITING Phase PHASE3
NCT07440290 DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. Status RECRUITING Phase PHASE2/PHASE3
NCT07432932 Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients Status RECRUITING Phase N/A
NCT07172958 Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) Status RECRUITING Phase PHASE1
NCT07095517 Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors Status RECRUITING Phase PHASE1
NCT06988475 DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations Status RECRUITING Phase PHASE2/PHASE3
NCT06632236 5G-EMERALD: Amivantamab in Malignant Brain Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06630260 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours Status RECRUITING Phase PHASE1/PHASE2
NCT06380816 A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06320067 A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer Status RECRUITING Phase PHASE3
NCT06289374 Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery Status RECRUITING Phase N/A
NCT06086574 Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer Status RECRUITING Phase N/A
NCT06045910 A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies Status RECRUITING Phase PHASE1/PHASE2